Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
doi: 10.1038/cr.2015.139 130 ShiJZhaoYWangKShiXWangYHuangHet al
Retatrutide is an investigational peptide therapy being studied for the treatment of obesity and type 2 diabetes
GLP-1 has been shown to potently inhibit several aspects of digestive function, including gastric emptying, gastric secretion and pancreatic secretion
Emerging data suggest that they may improve health across a range of diseases, including heart disease, addiction, some kinds of cancers, and dementia
showed that CNS administration of the MC4R antagonist, SHU9119, completely blocked leptin-induced increase in BAT UCP1 mRNA expression [38]